China Life approves CNY 0.36 dividend for China Life stock

Published on 10/05/2026 at 11:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue hit CNY 434.6 billion in the first half of 2026, up 81.5 percent. China Life stock costs EUR 3.12 on October 5, 2026 after EUR 3.10.

China Life, CNE1000002L3, Illustration mit AI erstellt.

China Life was trading at EUR 3.12 at Lang & Schwarz on October 5, 2026 at 11:02 a.m. CEST, while the insurer approved a CNY 0.36 interim dividend per share on September 24, 2026, according to MarketScreener. The dividend is payable on November 18, 2026, with October 8, 2026 set as the ex-dividend date.

Dividend date meets stronger results

The payout is tied to the six months ended June 30, 2026, giving investors a concrete return event alongside the insurer's latest operating figures. The dividend approval also places the October 8 ex-dividend date immediately ahead of the November payment date.

According to FSMOne on October 1, 2026, total revenue reached CNY 434.6 billion in the first half of 2026, up 81.5 percent from the year-earlier period. The result exceeded the CNY 327.0 billion forecast cited in the same report, creating a quantified comparison beyond the dividend story.

Profit growth raises the stakes

Net profit attributable to shareholders reached CNY 134.5 billion in the first half of 2026, a 228.6 percent year-over-year increase, while new business value rose 33.7 percent to CNY 38.2 billion, according to FSMOne. Revenue therefore grew more slowly than reported profit, highlighting how investment returns amplified the first-half earnings profile.

The same report said China Life raised its target price to HKD 39.10 on September 8, 2026, equivalent to a stated 32.1 percent potential upside at that date. That target applies to the Hong Kong-listed share, not the euro quotation used for the reference price in Germany.

Capital injection changes the backdrop

China Life Insurance Group is due to receive CNY 35.0 billion from China's Ministry of Finance. Reuters reported on September 7, 2026, that the funds are intended to ease solvency constraints and support longer-term equity investment.

Reuters also reported that the broader package was smaller than the CNY 200.0 billion the market had previously expected, while analysts described the measure as supportive but potentially relevant to dilution concerns. For China Life, the result is a stronger capital narrative alongside a stock valuation that still depends heavily on investment performance.

China Life stock stays near EUR 3

China Life stock was trading at EUR 3.12 at Lang & Schwarz on October 5, 2026 at 11:02 a.m. CEST, up 0.65 percent versus the EUR 3.10 prior close at Lang & Schwarz on October 2, 2026. The primary listing is on the Shanghai Stock Exchange, where the finance data snapshot dated September 30, 2026 showed a CNY 1,037.3 billion market capitalization and a CNY 32.32 to CNY 51.92 52-week range.

The next earnings date is October 30, 2026, according to Investing.com. The further course of trading is shown by the continuously updated real-time quote of China Life stock.